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The causation of anaemia is multifactorial in developing 
countries and includes micronutrient deficiencies (e.g. iron, 
folate, vitamin B12), chronic worm infections (e.g. hookworm, 
trichuris, schistosomiasis), haemoglobinopathies, cancer and 
chronic non-communicable disease such as chronic kidney 
disease and heart failure.
Anaemia is a major cause of morbidity in malaria, HIV and 
tuberculosis and is an independent prognostic marker in HIV. 
It also contributes to the progression of HIV and tuberculosis.1 
In Africa, anaemia is particularly common in individuals 
infected with soil-transmitted helminths or schistosomes. Blood 
loss in hookworm infections such as Necator americanus and 
Ankylostoma duodenale is strongly and linearly correlated with 
worm load and faecal egg count.2 Polyparasitism (infection 
with several parasites) is common in poor communities and 
leads to a 5 - 8-fold increase in anaemia. Anaemia has therefore 
been suggested as a useful indicator of neglected disease 
burden and control2 as it is a marker of morbidity rather 
than an indicator of infection by particular parasites. Iron 
deficiency often co-occurs with neglected infectious tropical 
diseases, and treatment of worm infection in combination 
with iron supplementation may lead to faster improvement 
of haemoglobin levels. The recently introduced Haemoglobin 
Colour Scale (HCS) can be used by non-laboratory health 
workers who have only a few hours’ training and avoids the 
need for and transportation of venous samples.2  
In this issue of the SAMJ two very interesting studies from 
Uganda3,4 highlight the multifactorial burden of anaemia in 
Africa. 
Mukaya et al.3 report on a carefully conducted, cross-
sectional descriptive study of 395 hospital patients, of whom 
255 (64%) had anaemia. This was most commonly microcytic 
hypochromic (34%), with a mixture of nutrient deficiency and 
infections such as tuberculosis (22.7%) being the most common 
clinical diagnosis. Splenomegaly, HIV infection and a low body 
mass index were independently associated with anaemia in 
this study.
Infections such as HIV and tuberculosis are usually 
associated with a normocytic, normochromic anaemia of 
chronic disorder. However, chronic inflammation can coexist 
with iron deficiency, leading to microcytic features, as were 
possibly seen in the study by Mukaya et al. Data on iron 
status, patients’ medications and level of immunosuppression 
could not be collected and therefore did not allow for a better 
understanding of the relationship between anaemia, HIV and 
tuberculous infection.  
The authors found a low prevalence of hookworm infection 
of 9.1%, demonstrated by ova in the stool, which the authors 
explained by successful de-worming programmes done in line 
with Uganda’s National Anaemia Policy.
Kuule et al.4 report on 157 patients with heart failure 
attending a large referral hospital in Uganda, Mulago Hospital. 
Interestingly, this is the same hospital where the study by 
Mukaya and colleagues showed that 64.3% of the 225 patients 
had anaemia at admission. This is much higher than the level 
of anaemia we reported in heart failure patients from South 
Africa.5,6 However, the patients in Uganda presented with 
an even more advanced stage of the disease and most had 
chronic heart failure. Most patients (88%) had a normocytic, 
normochromic anaemia, fitting the criteria for anaemia of a 
chronic disorder. Unfortunately the authors did not report 
on underlying HIV or tuberculosis, making comparison with 
the study done by Mukaya difficult. However, with a 64% 
prevalence of anaemia reported in Mukaya et al.’s study3 on a 
population from the same hospital it is likely that some of the 
chronic heart failure patients had alternative or concomitant 
causes leading to the development of anaemia.
Anaemia in heart failure is a complex problem, as 
highlighted in detail in the study by Kuule et al.4 However, the 
pathophysiology is poorly understood. It typically involves 
numerous features such as iron and vitamin deficiency, 
haemodilution, insidious blood loss, bone marrow depression, 
angiotensin system blockade and resistance to erythropoietin. 
Chronic kidney disease is very common in patients with 
heart failure, and for these patients the prognosis is often 
poor.7 It has been suggested that decreased cardiac output, 
increased inflammation, oxidative stress and activation of 
the neurohormonal system may challenge kidney function in 
patients with chronic heart failure. 
However, patients with hypertensive heart disease leading 
to heart failure may have underlying hypertensive kidney 
disease. Calculation of the estimated glomerular filtration 
rate (GFR) using the Modification of Diet in Renal Disease 
(MDRD) abbreviated formula and including an adjustment 
for black race is important.8 Approximately 27% of a cohort of 
281 newly diagnosed South African patients from Soweto with 
hypertensive heart failure had evidence of renal dysfunction 
defined by an estimated GFR of <60 ml/min/173 m2.7
Assessment of anaemia in chronic heart failure patients 
might have implications other than being an additional marker 
of advanced disease.  Klapholz and colleagues reported 
recently on the safety and tolerability of darbopoetin-alpha  as 
a form of treatment in patients with anaemia and symptomatic 
heart failure, showing that erythropoietin was well tolerated.9 
Outcome studies using darbopoetin in chronic heart failure are 
under way.  
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In conclusion, given the high prevalence of anaemia in 
some regions in Africa, more studies to evaluate the causes of 
anaemia in the area of HIV and the increase in chronic diseases 
such as hypertensive heart disease are needed.
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